QUEBEC CITY, February 19, 2025--(BUSINESS WIRE)--Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions ...
The Company also announces that it has closed a non-brokered private placement for aggregate gross proceeds of $334,500.33 (the "Offering"). The Offering consisted of the issuance of 1,967,649 units ...
As more people look for natural health treatments, they look at the true journey of the products they plan to apply to their skin. Right from how sustainable the company is to where the ingredients ...
Ms. Sybil Dahan takes on the role of Devonian’s Chairperson of the Board of Directors Mr. Pierre Montanaro takes on the role of Devonian’s President & CEO. Dr André P. Boulet takes on the role of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback